|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
430
|
Wed, 8/5/09, 8:30 AM - 10:20 AM | CC-102A |
| Clinical Trial Simulation Sample Size and Decision Analysis - Contributed - Papers | ||
|
Biopharmaceutical Section |
||
| Chair(s): Brian L. Wiens, Gilead Sciences, Inc. | ||
| 8:35 AM |
Sample Size and Power Analysis for PG and PGB Trials Using Parametric Tests —  Mallikarjuna Rettiganti, The Ohio State University
|
|
| 8:50 AM |
Simulation Modeling Approaches: Applications for Analysis and Design of Islet Cell Transplant Clinical Trials — Maithili Daphtary, FDA; Hong Yang, FDA; Bruce S. Schneider, FDA; Jawahar Tiwari, FDA; Steven A. Anderson, FDA
|
|
| 9:05 AM |
Evaluating the Efficiencies of Adaptive Design Trials - Case Studies Based on Real Clinical Trial Data — Suvajit Samanta, Merck & Co., Inc.; Weili He, Merck & Co., Inc.
|
|
| 9:20 AM |
Sample Size Estimation for Trials with Recurrent Events as the Primary Endpoint — Kuolung Hu, Amgen, Inc.; Robert A. Parker, Amgen, Inc.
|
|
| 9:35 AM |
Estimation vs. Hypothesis Testing in a Decision Analytic Framework — Duane Snavely, Merck & Co., Inc.; Kenneth Liu, Merck & Co., Inc.; Richard Entsuah, Merck & Co., Inc.
|
|
| 10:05 AM | Floor Discussion | |
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |